title: [Nephrogenic systemic fibrosis].
abstract: A scleromyxedema-like disease was recognized in 1997. In 2000 this disorder was first published and termed nephrogenic fibrosing dermopathy because all patients had advanced renal failure. In 2006 it was discovered that the patients had a history of a preceding contrast-enhanced magnetic resonance imaging (MRI). All patients had acute or chronic severe renal insufficiency with a glomerular filtration rate (GFR) <30 ml/min per 1.73 m(2). So far a total of about 215 patients with this new skin disorder have been reported to international registries. The skin thickening has a typical histology and begins in the peripheral extremities and progresses proximally, including also the abdominal wall and the head in some patients. NSF involves not only the skin, but also the muscles and other organs (e.g., lungs, heart, eyes) in some patients. Therefore the term nephrogenic systemic fibrosis (NSF) was introduced. Skin fibrosis and sclerosis are usually progressive with disabling contractures of involved joints (knees, hands, feet). NSF may be lethal in up to 28% of patients. Spontaneous remissions are rare. No generally accepted treatment is available. So far, the pathogenesis is not well understood. One hypothesis supposes a role of gadolinium liberated from the contrast agents. As patients with acute or chronic advanced renal failure (GFR <30 ml/min per 1.73 m(2)) including those with hepatorenal dysfunctions are at high risk to develop NSF after exposure to gadolinium-based contrast agents, contrast-enhanced MRI should be avoided in this group and alternative diagnostic procedures should be used whenever possible.
authors: Schwerpunkt Nephrologie, Medizinische Klinik und Poliklinik I, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377 München, Deutschland. walter.samtleben@med.uni-muenchen.de
authors: W
authors: W
authors: Samtleben
mesh_terms: D003287:Contrast Media / Q000009:adverse effects*; D018450:Disease Progression; D005355:Fibrosis / Q000139:chemically induced / Q000473:pathology; D019786:Gadolinium DTPA / Q000009:adverse effects*; D005919:Glomerular Filtration Rate; D006801:Humans; D016030:Kidney Transplantation; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications* / Q000628:therapy; D012307:Risk Factors; D053718:Scleromyxedema / Q000139:chemically induced*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
chemical_list: D003287:Contrast Media; D019786:Gadolinium DTPA
references: Am J Clin Dermatol. 2006;7(4):237-47
references: 16901184
references: Br J Dermatol. 2003 Mar;148(3):563-8
references: 12653751
references: Nephrol Dial Transplant. 2006 Apr;21(4):1104-8
references: 16431890
references: Clin Exp Dermatol. 2004 May;29(3):258-60
references: 15115505
references: Ann Intern Med. 1999 Mar 16;130(6):461-70
references: 10075613
references: J Vasc Interv Radiol. 2007 Mar;18(3):331-3
references: 17377176
references: Semin Dial. 2003 May-Jun;16(3):276-80
references: 12753692
references: Invest Radiol. 1996 Oct;31(10):619-24
references: 8889650
references: Am J Dermatopathol. 2003 Jun;25(3):204-9
references: 12775982
references: Methods Find Exp Clin Pharmacol. 1996 Sep;18(7):437-42
references: 8900215
references: Br J Dermatol. 2004 Mar;150(3):596-7
references: 15030351
references: AJR Am J Roentgenol. 2007 Feb;188(2):586-92
references: 17242272
references: Int J Dermatol. 2007 May;46(5):447-52
references: 17472669
references: J Am Soc Nephrol. 2006 Sep;17(9):2359-62
references: 16885403
references: Br J Dermatol. 2005 Mar;152(3):531-6
references: 15787823
references: Dermatology. 2004;209(1):50-2
references: 15237268
references: J Am Acad Dermatol. 2007 Jan;56(1):21-6
references: 17097388
references: Lancet. 2000 Sep 16;356(9234):1000-1
references: 11041404
references: Fundam Clin Pharmacol. 2006 Dec;20(6):563-76
references: 17109649
references: Curr Opin Rheumatol. 2003 Nov;15(6):785-90
references: 14569211
references: Radiat Med. 2006 Jul;24(6):445-51
references: 16958426
references: Am J Kidney Dis. 2005 Oct;46(4):763-5
references: 16183434
references: Am J Dermatopathol. 2001 Oct;23(5):383-93
references: 11801769
references: Nephrol Dial Transplant. 2005 Jan;20(1):220-2
references: 15632355
references: Nephron. 1976;16(1):31-41
references: 1244564
references: Invest Radiol. 2007 Feb;42(2):139-45
references: 17220732
references: J Pediatr. 2003 Nov;143(5):678-81
references: 14615747
references: Arch Dermatol. 2003 Jul;139(7):903-6
references: 12873886
references: J Am Acad Dermatol. 2007 Jan;56(1):27-30
references: 17109993
references: Semin Arthritis Rheum. 2006 Feb;35(4):238-49
references: 16461069
references: Acta Radiol. 2001 May;42(3):339-41
references: 11350296
references: Acad Radiol. 1998 Jul;5(7):491-502
references: 9653466
references: Arch Pathol Lab Med. 2006 Feb;130(2):209-12
references: 16454565
references: Dermatology. 2004;208(3):278-80
references: 15118390
references: Am J Med. 2003 May;114(7):563-72
references: 12753880